TUESDAY, April 11, 2017 -- In a significant shift, a key health advisory panel plans to soften its recommendation against prostate-specific antigen (PSA) screening for detecting prostate cancer.
In 2012, the U.S. Preventive Services Task Force recommended that men no longer get their PSA tested. That recommendation was based on evidence that PSA screening resulted in overdiagnosis and unnecessary treatment that could leave men impotent and incontinent.
SATURDAY, March 25, 2017 -- MRI screening might greatly reduce overdiagnosis and overtreatment of prostate cancer in older men, a preliminary study suggests.
Compared to the current screening method, MRI can reduce overdiagnosis of prostate cancer by 50 percent, and unnecessary biopsies by 70 percent in men over 70, Dutch researchers reported Saturday at a conference in England.
WEDNESDAY, March 15, 2017 -- Men are more likely than women to die after suffering an osteoporosis-related fracture, researchers report.
Osteoporosis, a disease where bones become weak and brittle, affects more than 44 million Americans. It contributes to about 2 million fractures a year, with women suffering more of these broken bones than men.
TUESDAY, Feb. 21, 2017 -- Testosterone treatment can boost bone density and reduce anemia in older men with low levels of the hormone, but it might also open the door to future heart risks, a new set of trials suggests.
The findings come in the last four studies to be reported out of the Testosterone Trials, a set of seven overlapping federally funded year-long clinical trials conducted at 12 sites across the United States.